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Abstract
Introduction
This retrospective study will aim compare Cyberknife SBRT and VMAT SBRT lung plans
quality when the Cyberknife plans are replanned to have a comparable treatment time to the
VMAT plans. Having data to show the difference in plan quality between the two treatment
techniques could be a useful tool when deciding the best treatment option.

Methodology
Select ten SBRT lung patients who were all treated using the Cyberknife and plan a comparable
VMAT treatment for each. Modify the original Cyberknife treatment plan so that the treatment
time is similar to that of the corresponding VMAT plan. Then, evaluate and compare the quality
of the two plans based on maximum heart dose, conformity index, mean heart dose, and
ipsilateral lung V20.

Preliminary Literature Review
While researching this topic, many studies were found comparing the quality of SBRT lung
treatments on the Cyberknife compared with conventional linac SBRT lung treatments. Other
studies compared the doses to critical normal structures and tumor dose, as well as local control
and recurrence, but what was not found in these studies was the delivery time difference between
the two methods.

Conclusion
Cyberknife plans have good plan quality when treatment times are relatively long. However, the
plan quality is degraded when plans are modified to have similar treatment times as VMAT plans.
VMAT SBRT lung treatments have shown to have better plan quality in terms of conformity index,
ipsilateral lung V20 dose, and maximum heart dose.
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Introduction
According to the Center for Disease Control and Prevention (2019), lung cancer is the
leading cause of cancer deaths in the United States of America, making up almost 25% of all cancer
deaths. Each year, more people die of lung cancer than of colon, breast, and prostate cancers
combined. Due to the prevalence and impact of this disease, it is imperative to find the best
treatment options available. Surgery is one option for lung cancer treatment. Surgery is the
preferred method and has the best chance of cure. However, there are situations in which surgery
cannot successfully be performed. Some reasons that limit surgery are related to the size, spread,
or location of the tumor. Chemotherapy and radiation therapy are also options for lung cancer
treatment. Studies have shown favorable outcomes when utilizing a stereotactic technique for lung
cancer treatment 5. Stereotactic body radiotherapy (SBRT) is a highly precise radiotherapy
technique used for the treatment of small to moderate tumors. SBRT can be considered one of the
most significant advances in modern radiotherapy because it utilizes accurate tumor delineation,
conformal treatment planning, motion management, and sophisticated image guidance to deliver
high doses in fewer fractions. The goal of SBRT is to complete ablate the tumor, thus providing a
similar outcome to complete resection of the tumor. One common prescription and fraction scheme
for SBRT lung treatment is 5000cGy delivered in 5 fractions. SBRT has recently become the
standard of care in early-stage inoperable lung cancer 6.
CyberKnife can be a power tool for treating lung tumors. Many tumors are challenging to
treat conventionally due to their location relative to critical normal structures. The CyberKnife can
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utilize treatment angles that a conventional linear accelerator is not capable of, making it ideal for
SBRT lung treatments. The Journal of Medical Physics describes the CyberKnife as a lightweight
linear accelerator fitted onto an industrial robot 3. The robot arm can treat with six degrees of
freedom. The table used in the CyberKnife treatment system is also a robot with six degrees of
freedom. This allows for countless angle combinations for each beam. The treatments with a
Cyberknife are also non-isocentric, allowing the beam to come from any angle. The CyberKnife
can deliver a high dose in a very conformal manner, minimizing surrounding tissue dose. The
Cyberknife has a sophisticated imaging system which allows for intrafractional monitoring of the
patients’ position as well as tumor tracking. The downside to treating SBRT lung cases on a
CyberKnife is the long treatment times. Some treatments take over an hour to deliver. This long
treatment delivery time is not feasible for a lot of patients. As patients become uncomfortable and
move, the treatment delivery time becomes even longer. Every time there is patient motion which
disrupts the respiration model that is tracking the tumor, a new model must be made. This involves
taking images at every phase of the respiratory cycle and can be quite time consuming. Creating
an accurate model for tumor tracking becomes more difficult to do the longer treatments take. This
is frustrating for the patients, as well as the therapists and doctor. With the advancements made in
VMAT planning, respiratory gating, and imaging, more SBRT lung cases are being planned on a
conventional linear accelerator.
This retrospective study will compare CyberKnife and VMAT SBRT lung plan quality
when the CyberKnife plans are replanned to have a comparable treatment time to the VMAT plans.
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The results show how plan quality is affected when treatment times are similar. Some extremely
conformal CyberKnife plans are nearly impossible for the patient to get through due to the long
delivery time. A plan is only good if it is possible to treat it correctly. Having the data to show the
comparison of plan quality when VMAT and CyberKnife SBRT lung treatments are planned for
approximately the same treatment delivery time could be a useful tool. If treatment time is a critical
concern in deciding which treatment option is best for the patients, the provider would have
information regarding which plan would offer the best plan quality.
The purpose of this study is to show the difference between VMAT and CyberKnife SBRT
lung treatments when comparing the max heart dose, conformality indexes, V20 ipsilateral lung
dose, and mean heart dose, when the treatment times are made comparable. We will see if
CyberKnife SBRT is still a superior plan when the beams and treatment nodes are limited to
produce a plan that has a similar treatment delivery time as VMAT SBRT.
Is there similar plan quality between Cyberknife SBRT and VMAT SBRT lung treatments
when Cyberknife plans are modified to have comparable treatment times?
Null hypothesis (𝐻0 ): There is no difference in plan quality between Cyberknife SBRT
lung plans and VMAT SBRT lung plans when the Cyberknife plans are modified to have a similar
treatment delivery time.
Alternative hypothesis (Ha): There is significant difference in plan quality between
Cyberknife SBRT lung plans and VMAT SBRT lung plans when the Cyberknife plans are
modified to have a similar treatment delivery time.
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Literature Review
Surgery is one option for lung cancer treatment. If surgery cannot successfully be
performed, generally due to the size, spread, or location of the tumor, chemotherapy and radiation
therapy are also options. This study will focus on radiation therapy, specifically the use of
stereotactic body radiotherapy (SBRT). The standard fractionation dose for external beam
radiation is generally 1.8-2Gy per fraction. However, the alpha/beta ratio differences of the healthy
tissue surrounding the tumor can significantly affect the fraction, Tumor Control Probability (TCP)
and Normal Tissue Complication Probability (NTCP). Alpha and beta are parameters used to
describe the cells radiosensitivity. The linear quadratic model describes the survival probability of
the cell after radiation exposure. Each type of tissue has a ratio that reflects the response to
radiation dose. If the alpha/beta ratio of the tumor is lower than the surrounding healthy tissue, a
high dose per fraction increases the tumor control probability. There are significant radiobiological
advantages to treating with high dose per fraction regimens8. Studies have shown favorable
outcomes when utilizing a SBRT technique for lung cancer treatment 5. SBRT is a highly precise
radiotherapy technique used for the treatment of small to moderate tumors. SBRT can be
considered one of the most significant advances in modern radiotherapy. SBRT utilizes accurate
tumor delineation, conformal treatment planning, motion management, and sophisticated image
guidance to deliver high doses in fewer fractions. SBRT has now become the standard of care in
early stage medically inoperable lung cancer 6.
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Aznar discusses how the technological advancements in image guidance and motion
management are enabling the treatment of more challenging cases 1. These advancements are
allowing more patients to be eligible to receive SBRT. With this increase in patient volumes comes
the increased need to know the best plan for each patient.
Volumetric modulated arc therapy (VMAT) is a popular option for planning SBRT
treatments of the lung. These plans are shown to be highly conformal, delivering high doses to the
tumor while minimizing dose to surrounding critical normal structures. One study showed that
VMAT treatments are much more efficient than intensity modulated radiotherapy (IMRT) 5. The
Journal of Applied Clinical Medical Physics published a study comparing and volumetricmodulated arc radiotherapy in stereotactic body lung radiotherapy. This study did show some
marginal differences in the two types of SBRT lung treatments. The most notable difference was
the greater monitor units for the CyberKnife plans, therefor greater delivery efficiency with VMAT
than with the CyberKnife plans 2.
Another research article by Ricotti which evaluated CyberKnife SBRT treatments, reported
that the average total treatment time was 64 minutes, ranging from 31-156 minutes 5. CyberKnife
plans tend to be superior in terms of conformality indexes and dose homogeneity, but the tradeoff
is usually a much longer treatment time. There are certain patients who cannot tolerate long
treatment times, making CyberKnife SBRT an unrealistic option for them. One retrospective study
completed by Suhong compared the quality of plans and planning time between Cyberknife SBRT
lung treatments and VMAT treatments, but the gap in this research was the actual treatment
delivery time4.
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One notable study, “Fiducial-Less SBRT of the Lung: VMAT Versus CK” by Daniel M.
Arsenault, MD, Maria I. Monterroso, MS, Zhendong Wang, PhD, Jean L. Wright, MD, showed
plan quality comparisons between VMAT and Cyberknife SBRT lung treatments, and mention of
Cyberknife treatment times generally being longer was made, however there was no mention of
the actual treatment times or time difference between the plans to show if there was a significant
different in treatment delivery time. There were also only 10 patients in this study and the research
article stated that a follow up study involving a larger sample would be beneficial for more data.
This study will aim to show the difference between VMAT and Cyberknife SBRT lung
treatment plans when comparing the conformality indexes, dose to surrounding critical normal
structures, and overall plan quality when the treatment times are made comparable. We will see if
Cyberknife SBRT is still a superior plan when the beams and treatment nodes are limited to
produce a plan that has a similar treatment delivery time as VMAT SBRT.
In general, limiting beam angles will result in less conformality. It may also result in higher
dose to surrounding critical structures. Cyberknife plans tend to be highly conformal with ultralow dose to surround organs at risks to the wide range of beam angles used.

Methods and Materials
Subjects
In this retrospective study, radiation treatment plan quality was evaluated and compared
between Cyberknife SBRT lung plans and Truebeam VMAT SBRT lung plans when treatment
delivery times were relatively the same. Criteria for subject selection included: Tumor location
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and prescription dose. The study included ten patients, treated to a total dose of 5000cGy in 5
fractions to a single, inferior lung tumor. Three participants had left-sided tumors and seven
participants had right-sided tumors. Age of participants ranged from fifty-seven to eighty-nine
with an average age of seventy-one years old. Of the study participants, four were male and six
were female. All patients received diagnoses of lung cancer with varying subtypes.
IRB
All patient information used for this research was anonymized. Patient plans were created
in Eclipse under a study number only, no names or hospital identification numbers were used.
Study participates where given a study number and all data collected was organized by this
number. This retrospective study presents no more than minimal risk to patient privacy and every
effort was made to ensure that there was strict compliance with the Health and Insurance
Portability Act of 1996 (HIPPA). Research was approved through the IRB at SCL Health Cancer
Centers of Montana and Grand Valley State University on February 3, 2022.
Materials
Study participants were initially simulated on a Toshiba Aquilion 64 slice scanner with 1millimeter-thick slices. Two scans were completed to assess tumor motion; one scan was done at
inspiration and one scan was done at expiration. All planning scans were completed in the supine,
headfirst position utilizing a breath hold technique. All patients were scanned on the same memory
foam cushion; immobilized with a knee roll, and feet banded together for maximum comfort and
reproducibility. All initial plans used in this study were contoured and planned by a Medical
9

Physicist with extensive Cyberknife planning experience, using Accuray Precision version 3.1.
All contours and plans were approved by the attending Radiation Oncologist. All VMAT SBRT
plans were generated using Eclipse Version 15.6. and planned by a Medical Dosimetry Student
who followed hospital procedures and guidelines for planning SBRT lung treatments.
Design and Procedure
The original planning CT and corresponding structure set and dose for each patient was
exported from the Accuray planning system, anonymized by the Medical Physicist, and imported
into Eclipse. Study participants were assigned a number for the study and all information and data
collected was organized by using this number only. The same structure set: non-target contours,
PTV, and GTV that were used for the Cyberknife SBRT plan was duplicated for the Eclipse SBRT
plan. Additional optimization structures were generated for SBRT VMAT planning. SBRT VMAT
plans were then optimized by a Medical Dosimetry student. All plans were completed to a
prescribed dose of 5000cGy in 5 fractions. The treatment time for each VMAT plan was noted and
then the original Cyberknife plan was modified to have a similar treatment time. Cyberknife plans
were modified by using the Precision planning optimization parameters to reduce overall treatment
delivery time. The planning template was changed to the short path option. The maximum segment
monitor units and maximum beam monitor units were also changed to decrease overall beam
times.
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Contouring
In addition to the original contours created by the planning Medical Physicist, the following
contours were generated for each patient and utilized in the VMAT SBRT planning. While in the
Contouring tab of Eclipse, a structure was made called CW-2cm. The CW-2cm structure was the
portion of the chest wall near the tumor minus 2 cm. The PTV, delineated by the Physician, was
copied to a structure called PTV-opti. There were three planning rings created for each plan. A
high dose ring (Ring HD), medium dose ring (Ring MD), and a low dose ring (Ring LD). The
rings were made utilizing the “Extract Wall” tool. The High Dose ring was created by extracting
the PTV-opti with an outer wall margin of 0.6cm and an inner wall margin of -0.10cm. The
medium dose ring was created by extracting the PTV-opti with an outer wall margin of 1.3cm and
an inner wall margin of -0.6cm. The low dose ring was created by extracting the PTV-opti outer
wall 2.5cm and the inner wall -1.3cm. A structure called CW-PTVoptiexp was created with the
“Crop” tool by removing the part of the CW-2cm that extended inside the PTV-opti with an
additional margin of 0.5cm.
External Beam Planning
Once in External Beam Planning, each plan was set up with two arcs. For left-sided tumors
the clockwise arc was set to rotate from 30 degrees to 181 degrees with a 45-degree collimator.
The counterclockwise arc was set to start at 181 degrees and end at 30 degrees with a collimator
angle of 315 degrees. For right-sided tumors the clockwise arc started at 181 degrees and ended at
30 degrees with a 45-degree collimator angle. The counterclockwise arc started at 30 degrees and
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ended at 181 degrees with a collimator angle of 315 degrees. The MLC was fit to the PTVopti
structure with a uniform margin of 0.3cm.
Optimization
The PTV objective was given one upper constraint: 0% of the volume receiving 6500cGy
with a priority of 115. A lower constraint of 100% of the volume receiving 5050cGy with a priority
of 100. Another lower was assigned to PTV with 100% of the volume receiving 5100cGy. The
PTVopti was given one upper constraint of 0% of the volume receiving 6500cGy with a priority
of 115. Two lower constraints were also used. The first of 100% of the volume receiving 5050cGy
with a priority of 100 and the second of 100% of the volume receiving 5100cGy with a priority of
100. The high dose ring was given one upper constraint of 0% of the volume receiving 4500cGy
with a priority of 50. The medium dose ring was given an upper constraint of 0% of the volume
receiving 1800cGy with a priority of 50. The low dose ring was given a constraint of 0% of the
volume receiving 1000cGy and a priority of 50. The spinal cord+5mm structure was assigned an
upper constraint of 0% of the volume receiving 190cGy and a priority of 50. The CW-2cm
structure was given two upper constraints: the first of 0% of the volume receiving 3300cGy with
a priority of 50 and the second of 4% of the volume receiving 2700cGy and a priority of 50. The
skin rind structure was assigned one upper constraint of 0% receiving 1000cGy and a priority of
50.
Optimization was started and paused in level one to check the maximum dose for the Ring
LD and Ring MD. These ring constraints were lowered in 20% increments as needed during
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optimization. The LD ring and MD ring were kept above the PTV in the cost bar section of the
optimizer and increased by 200cGy at a time as needed to maintain this. Upon completion of
optimization, the plan was calculated, and the normalization was set to 100% covering 99.5% of
the target volume (PTV). The plans were then reoptimized once more. Upon completion of the
SBRT plans in Eclipse, plans were verified by the Medical Physicist and the treatment delivery
time was noted.
The original Cyberknife SBRT plan was modified to have a similar treatment delivery time
as its new corresponding Eclipse plan. The Cyberknife plans were all modified by using the
Precision optimization parameters to reduce overall treatment delivery time. The template was
changed to the short path option. The maximum segment monitor units and maximum beam
monitor units were also changed to decrease overall beam times. Once the Cyberknife plan was
modified to have a similar treatment time as the Eclipse SBRT plan, the plan quality was evaluated
by comparing conformality indexes, mean and max heart dose, and volume of the ipsilateral lung
receiving 20Gy (V20).
Data Analysis
All data was collected in an anonymized spreadsheet which used no patient names or
identifiers, only a study number assigned to each patient. The data was then analyzed using SAS
version 9.4 software by Grand Valley State University’s statistical consulting department.
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Quality metrics that were analyzed were maximum heart dose, conformity index, dose of
the ipsilateral lung receiving 20Gy (V20), and mean heart dose. Wilcoxson-Signed Rank tests
were used to evaluate the differences between the two types of plans.

Results
The goal of this study was to determine if there is a difference between VMAT and
CyberKnife SBRT lung treatment plan quality when comparing the max heart dose, conformality
indexes, V20 ipsilateral lung dose, and mean heart dose, when the treatment times are made
comparable. Ten patients with single inferior lung tumors, treated to a total dose of 5000cGy in 5
fractions were selected for this retrospective analysis.
Maximum Heart Dose
Cyberknife plans maximum heart doses ranged from 8cGy to 2900cGy. The median
maximum heart dose was 929cGy and the mean was 1154.9cGy. VMAT maximum heart doses
ranged from 17cGy to 1500cGy with a median of 890.5cGy and a mean of 776.80cGy. The WSR
test produced a P value of 0.048, a marginally significant result. Reference figure I on page 16.
Conformity Indexes
Conformity indexes for Cyberknife plans ranged from 1.1 to 1.7. The median CI was 1.375
and mean was 1.4. Conformity indexes for VMAT plans ranged from .98 to 1.2 with a median CI
of 1.1 and a mean of 1.078. The WSR test produced a P value of 0.002, which shows significance.
There were no outliers and the conformality index for all VMAT plans was smaller than that of
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the corresponding Cyberknife plan, which is indicative of being a more conformal treatment plan.
Reference figure II on page 17.
V20 Ipsilateral Lung Dose
Ipsilateral lung V20 doses for Cyberknife plans ranged from 1% to 8.9%. The median was
3% and mean was 3.69%. For the VMAT plans the ipsilateral V20 dose ranged from 0.3% to 3.3%
with a mean of 1.79% and median of 1.65%. The P value, which was also determined using WSR,
was .002. This shows significance with VMAT plans having lower V20 doses for the ipsilateral
lung. Mean heart doses for Cyberknife plans ranged from 2cGy to 600cGy and had a median dose
of 26.50 and a mean dose of 138.90cGy. Reference figure III on page 18.
Mean Heart Dose
Mean heart doses for Cyberknife plans ranged from 2cGy to 600cGy and had a median
dose of 26.50 and a mean dose of 138.90cGy. For the VMAT plans the mean heart doses ranged
from 2cGy to 400cGy. The median dose was 40cGy and the mean was 124cGy. The WSR P value
for mean heart dose was 0.625, which is not significant. Reference figure IV on page 19.

Discussion
Is there similar plan quality between Cyberknife SBRT and VMAT SBRT lung
treatments when Cyberknife plans are modified to have comparable treatment times? Having data
to show the difference in plan quality between the two treatment techniques can be a useful tool
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when deciding the best treatment option, especially when time is a crucial factor. VAMT SBRT is
a good option for patients not able to withstand longer than average treatment times.
Maximum heart dose showed a marginally significant result, which is expected with Dmax
results. One of the Cyberknife plans had more than one beam going through the heart. This would
drive up the maximum and mean heart dose of this specific plan. If more time had been spent
optimizing this specific plan, that maximum heart dose could have potentially been better
controlled and decreases. Treatment time of Cyberknife plans were reduced by limiting the beam
angles and treatment nodes. This explains the decrease seen in conformality, as well as the increase
in ipsilateral lung V20, from Cyberknife SBRT plan to VMAT SBRT plan. Less beam angles
generally relates to less conformal dose. Utilizing fewer beam entry options would drive up the
dose to the ipsilateral lung and the mean heart dose due to more dose having to go through these
critical structures rather than being spread throughout the chest area. The range of the mean heart
doses in this study was relatively low, thus indicating that the heart was far enough from the target
that the mean heart dose was not affected.
There is an extensive amount of research showing Cyberknife SBRT plans are superior to
VMAT SBRT plans. However, most of this research dose not factor in the treatment delivery time
difference between these two types of plans. Mean heart dose did not show a significant difference
between the two plans, this could be due to limiting the mean heart dose similarly in both plan
types during optimization, thus controlling the mean heart dose in both planning techniques.
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Limitations and Future Research
A limiting factor of this study was the small sample size of ten study participants. A small
sample size was chosen due to the researcher’s time limitations; however, it would be interesting
to recreate this study with a larger sample size to see if the conclusions vary. A worthwhile addition
to the data would be evaluating the robustness of the VMAT plans in more detail. Without some
type of intrafractional motion monitoring, such as surface guidance, the beam will remain on if a
patient moves and it goes unnoticed. A robust plan is essential for ensuring adequate coverage and
critical organ sparing.

Conclusion
Lung cancer is a common and often fatal disease in America. Finding the best treatment
approach to cure or control lung tumors is imperative. SBRT lung treatments have shown
promising results in controlling these tumors when surgery is not a viable option. There are
different SBRT treatment techniques that can be utilized. One powerful tool for treating SBRT
lung cases is the Cyberknife. Many tumors are challenging to treat conventionally due to their
location relative to critical normal structures. The Cyberknife machine can utilize treatment angles
that a conventional linear accelerator is not capable of, making it ideal for SBRT lung treatments.
Cyberknife can deliver a high dose in a very conformal manner, minimizing surrounding tissue
dose. The downside to these highly conformal treatments is the long treatment time. Many patients
cannot tolerate longer than average treatment times. As patients become uncomfortable and move,

17

the treatment delivery time becomes even longer. This is frustrating for the patients, as well as the
therapists and doctor. While Cyberknife plans have good plan quality when treatment times are
relatively long, the plan quality is degraded when plans are modified to have similar treatment
times as VMAT plans.
This study shows that VMAT SBRT lung treatments can have better plan quality in terms
of conformity index, ipsilateral lung V20 dose, and maximum heart dose when compared to time
constraint Cyberknife plans. With the advancements made in VMAT treatment planning and
image guidance, VMAT SBRT is a viable option for patients who cannot tolerate long treatments.

18

Tables and Figures
Figure I: Boxplot showing maximum heart dose between and Truebeam and Cyberknife plans.
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Figure II: Boxplot showing conformity index between Truebeam and Cyberknife plans.
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Figure III: Boxplot showing ipsilateral V20 lung dose between Truebeam and Cyberknife plans.
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Figure VI: Boxplot showing mean heart dose between Truebeam and Cyberknife plans.
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